| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/14/1999 | EP0907733A1 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 04/14/1999 | EP0907732A2 Polynucleotides encoding secreted proteins |
| 04/14/1999 | EP0907731A1 Metabotropic gaba(b) receptors, receptor-specific ligands and their uses |
| 04/14/1999 | EP0907730A1 Haemopoietin receptor and genetic sequences encoding same |
| 04/14/1999 | EP0907729A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS |
| 04/14/1999 | EP0907728A2 Promoter elements conferring root-preferred gene expression |
| 04/14/1999 | EP0907727A1 Yeast invertase gene as reporter system for isolating cytokines |
| 04/14/1999 | EP0907726A1 Chromosomal rearrangement by insertion of two recombination substrates |
| 04/14/1999 | EP0907720A1 Combined radiotherapy and immunotherapy to treat cancer |
| 04/14/1999 | EP0907719A1 Human cytokine polypeptide |
| 04/14/1999 | EP0907660A1 Scarecrow gene, promoter and uses thereof |
| 04/14/1999 | EP0907659A1 Synthetic inhibitors of hepatitis c virus ns3 protease |
| 04/14/1999 | EP0907377A1 Novel compounds |
| 04/14/1999 | EP0907376A1 Novel compounds |
| 04/14/1999 | EP0907375A1 Novel compounds |
| 04/14/1999 | EP0907370A1 Hla-a2.1 binding peptides and their uses |
| 04/14/1999 | EP0907312A1 Compositions and methods for taxol biosynthesis |
| 04/14/1999 | EP0832300A4 Cultured cell line that inducibly expresses the hepatitis b virus genome, and uses thereof for screening antiviral substances |
| 04/14/1999 | EP0821694A4 Conotoxin peptides |
| 04/14/1999 | EP0819119A4 Compounds, compositions and methods for generating chemiluminescence with phosphatase enzymes |
| 04/14/1999 | EP0777685B1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 04/14/1999 | EP0759940A4 A dna molecule encoding a mast cell function-associated antigen (mafa) |
| 04/14/1999 | EP0734436B1 Inhibition of dna methyltransferase |
| 04/14/1999 | EP0725793A4 Protease-derivatized cvf |
| 04/14/1999 | EP0682715A4 Diagnostic assays and kits for rna using rna binary probes and an rna-directed rna ligase. |
| 04/14/1999 | EP0658167B1 4,7-dichlorofluorescein dyes as molecular probes |
| 04/14/1999 | EP0643559B1 Diphtheria toxin receptor-binding region |
| 04/14/1999 | EP0618814B1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines |
| 04/14/1999 | EP0550661B1 Uses of gro genes and proteins |
| 04/14/1999 | EP0548200B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 04/14/1999 | EP0455668B1 Male flower specific gene sequences |
| 04/14/1999 | CN1214083A Mixture of recominant vaccinia vectors as polyenv vaccines for HIV |
| 04/14/1999 | CN1214082A Alkaline cellulase and method of producing same |
| 04/14/1999 | CN1214081A Polypeptides having phytase activity and nucleic acids encoding same |
| 04/14/1999 | CN1214080A Glycorprotein B of RFHV/KSHV subfamily of herpes viruses |
| 04/14/1999 | CN1214052A Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 04/14/1999 | CN1214050A Human tumor necrosis factor delta and epsilon |
| 04/14/1999 | CN1213699A Prodn. system of novel recombination adenovirus adjoint virus |
| 04/13/1999 | US5894078 Transgenic mouse expressing C-100 app |
| 04/13/1999 | US5894060 Identifying and isolating segments of mammalian dna with functional replicons targeted to methylated dna using restriction endonucleases |
| 04/13/1999 | CA2169942C Multiple integrative vectors and yarrowia lipolytica transformants |
| 04/13/1999 | CA2158750C Monoclonal antibodies to casein kinase i polypeptides |
| 04/13/1999 | CA2116562C Morphogen-induced modulation of inflammatory response |
| 04/13/1999 | CA2079584C Methods for trans-destabilization of specific proteins in vivo |
| 04/13/1999 | CA2064046C Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof |
| 04/13/1999 | CA2056743C Thermal cycler for automatic performance of the polymerase chain reaction with close temperature control |
| 04/13/1999 | CA2000661C A process for the production of transgenic plants with increased nutritional value via the expression of modified 2s storage albumins |
| 04/13/1999 | CA1340491C Interleukin-7 |
| 04/10/1999 | CA2246632A1 Novel mure |
| 04/10/1999 | CA2229440A1 Mammalian mesoderm induction early response (mier) gene family |
| 04/10/1999 | CA2225180A1 Non-mammalian mesoderm induction early response (mier) gene family |
| 04/09/1999 | CA2246635A1 Novel glucosaminidase |
| 04/08/1999 | WO1999016910A1 Method and kit for evaluation of hiv mutations |
| 04/08/1999 | WO1999016909A1 Methods to modulate blood pressure and diagnose bartter's syndrome type iii |
| 04/08/1999 | WO1999016907A2 Reagent and method for attaching target molecules to a surface |
| 04/08/1999 | WO1999016906A1 Disease association by locus stratification |
| 04/08/1999 | WO1999016905A1 Atm exon 24 variant as a cancer marker |
| 04/08/1999 | WO1999016904A1 Efficient linking of nucleic acid segments |
| 04/08/1999 | WO1999016903A1 Method for screening heat shock protein expression induction regulators |
| 04/08/1999 | WO1999016902A1 Bioassay for thyroid stimulating antibodies |
| 04/08/1999 | WO1999016894A1 Method for determining active agents |
| 04/08/1999 | WO1999016892A1 Bovine herpesvirus 2 (bhv-2) based vector and its uses |
| 04/08/1999 | WO1999016891A1 Methods of replicating virus in monocyte-derived macrophage cultures |
| 04/08/1999 | WO1999016890A2 Production of proteins in plant seeds |
| 04/08/1999 | WO1999016889A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumor treatment |
| 04/08/1999 | WO1999016888A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 04/08/1999 | WO1999016887A2 Compositions and methods for identifying pkb kinase inhibitors |
| 04/08/1999 | WO1999016886A1 Method for producing ergosterol and intermediate products thereof by means of recombinant yeasts |
| 04/08/1999 | WO1999016885A1 Killer t cell receptor recognizing human immunodeficiency virus |
| 04/08/1999 | WO1999016884A1 Fusion proteins comprising hiv-1 tat and/or nef proteins |
| 04/08/1999 | WO1999016883A2 STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN |
| 04/08/1999 | WO1999016882A1 LMB GENE OF $i(STREPTOCOCCUS AGALACTIAE) |
| 04/08/1999 | WO1999016881A1 Antigen protein and nucleic acid coding for said protein |
| 04/08/1999 | WO1999016880A2 Protein involved in abscisic acid signalling |
| 04/08/1999 | WO1999016879A1 Gene promoter sequences and uses thereof |
| 04/08/1999 | WO1999016878A1 Method of regulating gene expression |
| 04/08/1999 | WO1999016877A1 Amino-terminally truncated rantes as chemokine antagonists |
| 04/08/1999 | WO1999016876A1 Amino-terminally truncated mcp-2 as chemokine antagonists |
| 04/08/1999 | WO1999016875A1 A method for selectively controlling membrane protein display and protein secretion in eukaryotic cells |
| 04/08/1999 | WO1999016874A1 Nucleic acids coding for proteins capable of interacting with presenilins |
| 04/08/1999 | WO1999016873A1 Anticalins |
| 04/08/1999 | WO1999016872A1 Isoforms of the human vitamin d receptor |
| 04/08/1999 | WO1999016871A2 Nucleic acid catalysts with endonuclease activity |
| 04/08/1999 | WO1999016869A1 A process for the purification of plasmid dna |
| 04/08/1999 | WO1999016868A1 Tm4 conditional shuttle phasmids and uses thereof |
| 04/08/1999 | WO1999016867A1 Transgenic model comprising tcr alpha and beta chains |
| 04/08/1999 | WO1999016866A1 A method for generating nonpathogenic, infectious birnavirus from synthetic rna transcripts |
| 04/08/1999 | WO1999016859A1 Microbial agricultural chemical |
| 04/08/1999 | WO1999016858A1 Expression control sequences |
| 04/08/1999 | WO1999016832A1 Aromatic-substituted xanthene dyes |
| 04/08/1999 | WO1999016789A1 Apoptosis-related compounds and their use |
| 04/08/1999 | WO1999016788A1 Isolated proteins having retinol dehydrogenase activity, and which associate with retinol binding protein receptors |
| 04/08/1999 | WO1999016784A1 Ras-binding protein (pre1) |
| 04/08/1999 | WO1999016782A2 Regulation of gene expression |
| 04/08/1999 | WO1999016781A2 Automatable method for preparing samples which can be universally applied |
| 04/08/1999 | WO1999016780A2 Genetic sequences, diagnostic and/or quantification methods for the identification of staphylococci strains |
| 04/08/1999 | WO1999016467A1 Non-anaphylactic forms of allergens and their use |
| 04/08/1999 | WO1999016459A1 Apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |
| 04/08/1999 | WO1999016425A1 Lipid-modified insulin incorporated liposomes for selectively delivering cytotoxic agents to hepatoma cells |
| 04/08/1999 | WO1999016409A2 Gene therapy approaches to supply apolipoprotein a-i agonists and their use to treat dyslipidemic disorders |